[go: up one dir, main page]

GR20120100181A - Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων - Google Patents

Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων

Info

Publication number
GR20120100181A
GR20120100181A GR20120100181A GR20120100181A GR20120100181A GR 20120100181 A GR20120100181 A GR 20120100181A GR 20120100181 A GR20120100181 A GR 20120100181A GR 20120100181 A GR20120100181 A GR 20120100181A GR 20120100181 A GR20120100181 A GR 20120100181A
Authority
GR
Greece
Prior art keywords
lyophilized
medicinal
emulsions
new
cosmetic formulations
Prior art date
Application number
GR20120100181A
Other languages
English (en)
Inventor
Μαριαννα Αχιλλεα Παπαμιχαηλ
Σταυρος Νικολαου Πολιτης
Original Assignee
Μαριαννα Αχιλλεα Παπαμιχαηλ
Ρεκκας, Δημητριος Μιχαηλ
Σταυρος Νικολαου Πολιτης
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Μαριαννα Αχιλλεα Παπαμιχαηλ, Ρεκκας, Δημητριος Μιχαηλ, Σταυρος Νικολαου Πολιτης filed Critical Μαριαννα Αχιλλεα Παπαμιχαηλ
Priority to GR20120100181A priority Critical patent/GR20120100181A/el
Publication of GR20120100181A publication Critical patent/GR20120100181A/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε λυοφιλοποιημένη φαρμακοτεχνική και καλλυντικοτεχνική μορφή που προκύπτει από τη λυοφιλοποίηση γαλακτώματος, η οποία στερείται κύριων γαλακτωματοποιητών και συντηρητικών. Η μορφή της παρούσας εφεύρεσης προκύπτει από τη λυοφιλοποίηση γαλακτώματος το οποίο περιείχε τουλάχιστον μία υδατική φάση, μία λιπαρή φάση και έναν ή περισσότερους γαλακτωματοποιητές της κατηγορίας των τροποποιημένων ημισυνθετικών κυτταρινών χαρακτηριζόμενη επιπλέον από το ότι είναι ελεύθερη λοιπών γαλακτωματοποιητών και συντηρητικών. Οι μορφές της παρούσας εφεύρεσης παράγονται μέσω μίας διεργασίας που περιλαμβάνει τουλάχιστον ένα στάδιο γαλακτωματοποίησης, προτιμότερα χωρίς τη χρήση θερμότητας και ένα στάδιο λυοφιλοποίησης.
GR20120100181A 2012-03-28 2012-03-28 Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων GR20120100181A (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20120100181A GR20120100181A (el) 2012-03-28 2012-03-28 Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20120100181A GR20120100181A (el) 2012-03-28 2012-03-28 Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων

Publications (1)

Publication Number Publication Date
GR20120100181A true GR20120100181A (el) 2013-10-15

Family

ID=47189973

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20120100181A GR20120100181A (el) 2012-03-28 2012-03-28 Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων

Country Status (1)

Country Link
GR (1) GR20120100181A (el)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556394A1 (en) * 1990-11-06 1993-08-25 Nippon Shinyaku Company, Limited Lyophilized preparation and production thereof
US5472706A (en) * 1992-02-18 1995-12-05 Pharmos Corp. Dry compositions for preparing submicron emulsions
EP1980240A1 (en) * 2007-04-11 2008-10-15 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
EP2359812A1 (en) * 2010-01-18 2011-08-24 Cephalon France Oral lyophilised compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556394A1 (en) * 1990-11-06 1993-08-25 Nippon Shinyaku Company, Limited Lyophilized preparation and production thereof
US5472706A (en) * 1992-02-18 1995-12-05 Pharmos Corp. Dry compositions for preparing submicron emulsions
EP1980240A1 (en) * 2007-04-11 2008-10-15 Cephalon France Lyophilized pharmaceutical compositions and methods of making and using same
EP2359812A1 (en) * 2010-01-18 2011-08-24 Cephalon France Oral lyophilised compositions

Similar Documents

Publication Publication Date Title
EP4218807A3 (en) Zika virus vaccine
BR112017008165A2 (pt) anticorpos de domínio único direcionados contra antígenos intracelulares
GEP20166457B (en) Low-oil pharmaceutical emulsion compositions comprising progestogen
MX392345B (es) Emulsiones o microemulsiones para usarse en reseccion endoscopica de la mucosa y/o diseccion endoscopica de la submucosa
MX2017015881A (es) Formulaciones para vacunas contra la neoplasia y metodos para preparar las mismas.
EA201692213A1 (ru) Мицеллярный нанокомплекс
EA201591579A1 (ru) Способы лечения болезни крона при помощи анти-il-23 антитела
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
ZA202403393B (en) Synthetic chimeric poxviruses
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
WO2015061798A3 (en) Compositions and methods comprising yeast organisms and lipid extracts thereof
MX2016014906A (es) Preparaciones cosmeticas y/o dermatologicas extemporaneas.
PH12017500304A1 (en) Vaccine compositions against dengue virus diseases
BR112017004045A2 (pt) composições para formulação cosmética compreendendo uma mistura selecionada dentre manteiga de murumuru, manteiga de ucuuba, óleo de castanha, óleo de maracujá, manteiga de cupuaçu, óleo de açaí e/ou óleo de andiroba e/ou ésteres dos mesmos, bem como uso de uma mistura para preparação de um produto cosmético
EA201591581A1 (ru) Способы лечения псориаза при помощи анти-il-23 антитела
BR112017019358A2 (pt) combinações e formulações de dose fixa compreendendo etc1002 e ezetimiba e métodos de tratamento ou redução do risco de doença cardiovascular
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
BR112017009510A2 (pt) composições compreendendo ciclosporina
BR112016007526A2 (pt) formulação de tratamento contra hiv de atazanavir e cobicistat
WO2014140166A3 (en) Vaccine
BR112018012618A2 (pt) composições da nano emulsão de fluorocarbonos e métodos de preparação e uso dos mesmos
CL2018001779A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales.
EA201892003A1 (ru) Лечение атопического дерматита собак
IN2014DN09445A (el)
GR20120100181A (el) Νεες λυοφιλοποιημενες φαρμακοτεχνικες και καλυντικοτεχνικες μορφες λυοφιλοποιημενων γαλακτωματων

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees

Effective date: 20141002